Incyte Corporation is a biopharmaceutical company that develops and sells medicines. Its filings show it lobbies Congress on Medicare and Medicaid rules, including the Medicaid Drug Rebate program and the 340B drug discount program, and on access to innovative dermatology therapies and related provisions in the Orphan Cures Act. It hired W Strategies, LLC and reported about $240,000 in lobbying since 2026-01-20.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DARREN WILLCOX
The latest disclosures for this client.
W STRATEGIES, LLC
Q1W STRATEGIES, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
W STRATEGIES, LLC
W STRATEGIES, LLC
Q3W STRATEGIES, LLC
Q2W STRATEGIES, LLC
Q1